Epidemiology and risk factors for staphylococcal urinary tract infections in the Moroccan Casablanca area.


Journal

World journal of urology
ISSN: 1433-8726
Titre abrégé: World J Urol
Pays: Germany
ID NLM: 8307716

Informations de publication

Date de publication:
06 May 2024
Historique:
received: 14 01 2024
accepted: 05 04 2024
medline: 6 5 2024
pubmed: 6 5 2024
entrez: 6 5 2024
Statut: epublish

Résumé

This study aimed to ascertain the prevalence and risk factors for developing staphylococcal urinary tract infections (UTIs) in the Casablanca area of Morocco. In Casablanca, Morocco, a retrospective evaluation of 772 UTIs patients was conducted between January 2020 and December 2022. The research included two groups of patients: those with staphylococcal UTIs and those without. Sex, age, chronic illnesses, antibiotic exposure, urinary catheterization, urological surgery, and UTIs history were the risk variables assessed. We employed a logistic regression model to identify the characteristics that were predictive of staphylococcal UTIs. Eight staphylococcal species were responsible for 16.84% of UTIs in 772 non-repeating individuals. Patients infected with S. saprophyticus (35.38%) were the most common, followed by those infected with S. epidermidis (24.61%), S. aureus (13.85%), and S. hemolyticus (10.78%). Multivariate logistic regression analysis revealed that male sex (95% CI: 0.261-0.563), immunosuppression and immunosuppressive treatments (95% CI: 0.0068-0.64), chronic diseases (95% CI: 0.407-0.965), previous UTIs (95% CI: 0.031-0.228), frequency of urination more than 8 times a day (95% CI:1.04-3.29), frequency of urination once or twice a day (95% CI: 1.05-2.39), and urinary catheterization (95% CI: 0.02-0.22) were the most likely predictors of staphylococcal UTIs. In addition, a larger proportion of patients with staphylococcal UTIs were made aware of the risk factors associated with staphylococcal UTIs (52.31%, χ2 = 4.82, = 0.014). This is the first global study to evaluate the predictive factors for acquiring UTIs caused by staphylococci. Monitoring these factors will enable medical authorities to devise effective strategies for managing UTIs and combating antibiotic resistance.

Identifiants

pubmed: 38709302
doi: 10.1007/s00345-024-04981-8
pii: 10.1007/s00345-024-04981-8
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

296

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Rafik A, Abouddihaj B, Asmaa D, et al (2021) Antibiotic resistance profiling of Uropathogenic Enterobacteriaceae, Casablanca, Morocco. E3S Web Conf 319:01002. https://doi.org/10.1051/e3sconf/202131901002
Gajdács M, Ábrók M, Lázár A, Burián K (2020) Increasing relevance of Gram-positive cocci in urinary tract infections: a 10-year analysis of their prevalence and resistance trends. Sci Rep 10:17658. https://doi.org/10.1038/s41598-020-74834-y
doi: 10.1038/s41598-020-74834-y pubmed: 33077890 pmcid: 7573585
Assouma FF, Sina H, Dossou AD et al (2023) Antibiotic Resistance Profiling of Pathogenic Staphylococcus Species from Urinary Tract Infection Patients in Benin. Biomed Res Int 2023:e6364128. https://doi.org/10.1155/2023/6364128
doi: 10.1155/2023/6364128
Alshomrani MK, Alharbi AA, Alshehri AA et al (2023) Isolation of Staphylococcus aureus urinary tract infections at a community-based healthcare center in riyadh. Cureus. https://doi.org/10.7759/cureus.35140
doi: 10.7759/cureus.35140 pubmed: 37814740 pmcid: 10560542
Ehlers S, Merrill SA (2022) Staphylococcus Saprophyticus. In: StatPearls. StatPearls Publishing, Treasure Island (FL)
Natsis NE, Cohen PR (2018) Coagulase-negative Staphylococcus skin and soft tissue infections. Am J Clin Dermatol 19:671–677. https://doi.org/10.1007/s40257-018-0362-9
doi: 10.1007/s40257-018-0362-9 pubmed: 29882122
Issakhanian L, Behzadi P (2019) Antimicrobial agents and urinary tract infections. Curr Pharm Des 25:1409–1423. https://doi.org/10.2174/1381612825999190619130216
doi: 10.2174/1381612825999190619130216 pubmed: 31218955
Arias CA, Murray BE (2012) The rise of the Enterococcus: beyond vancomycin resistance. Nat Rev Microbiol 10:266–278. https://doi.org/10.1038/nrmicro2761
doi: 10.1038/nrmicro2761 pubmed: 22421879 pmcid: 3621121
Sader HS, Farrell DJ, Flamm RK, Jones RN (2014) Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalised with pneumonia in US and European hospitals: results from the SENTRY Antimicrobial Surveillance Program, 2009–2012. Int J Antimicrob Agents 43:328–334. https://doi.org/10.1016/j.ijantimicag.2014.01.007
doi: 10.1016/j.ijantimicag.2014.01.007 pubmed: 24630306
Maroc en chiffres | Téléchargements | Site institutionnel du Haut-Commissariat au Plan du Royaume du Maroc
SFM (2018) Référentiel en microbiologie médicale (REMIC 6.2), 6th ed. Société Française de Microbiologie, French
Selim S, Faried OA, Almuhayawi MS et al (2022) Incidence of vancomycin-resistant Staphylococcus aureus strains among patients with urinary tract infections. Antibiotics 11:408. https://doi.org/10.3390/antibiotics11030408
doi: 10.3390/antibiotics11030408 pubmed: 35326871 pmcid: 8944512
Bosco MJ, Jonas B, Evelyne K, Pauline K (2020) Urinary tract infection and antimicrobial resistance profile in patients attending Nemba District Hospital in Rwanda. Asian Journal of Medical Sciences 11:101–105. https://doi.org/10.3126/ajms.v11i6.29921
doi: 10.3126/ajms.v11i6.29921
Bizuayehu H, Bitew A, Abdeta A, Ebrahim S (2022) Catheter-associated urinary tract infections in adult intensive care units at a selected tertiary hospital, Addis Ababa. Ethiopia PLOS ONE 17:e0265102. https://doi.org/10.1371/journal.pone.0265102
doi: 10.1371/journal.pone.0265102 pubmed: 35316286
Storme O, Tirán Saucedo J, Garcia-Mora A et al (2019) Risk factors and predisposing conditions for urinary tract infection. Ther Adv Urol 11:1756287218814382. https://doi.org/10.1177/1756287218814382
doi: 10.1177/1756287218814382 pubmed: 31105772 pmcid: 6502981
Salari N, Karami MM, Bokaee S et al (2022) The prevalence of urinary tract infections in type 2 diabetic patients: a systematic review and meta-analysis. Eur J Med Res 27:20. https://doi.org/10.1186/s40001-022-00644-9
doi: 10.1186/s40001-022-00644-9 pubmed: 35123565 pmcid: 8817604
Dimitrijevic Z, Paunovic G, Tasic D et al (2021) Risk factors for urosepsis in chronic kidney disease patients with urinary tract infections. Sci Rep 11:14414. https://doi.org/10.1038/s41598-021-93912-3
doi: 10.1038/s41598-021-93912-3 pubmed: 34257397 pmcid: 8277778
Anggi A, Wijaya DW, Ramayani OR (2019) Risk factors for catheter-associated urinary tract infection and uropathogen bacterial profile in the intensive care unit in hospitals in Medan, Indonesia. Open Access Maced J Med Sci 7:3488–3492. https://doi.org/10.3889/oamjms.2019.684
doi: 10.3889/oamjms.2019.684 pubmed: 32002081 pmcid: 6980809
Patel PK, Advani SD, Kofman AD et al (2023) Strategies to prevent catheter-associated urinary tract infections in acute-care hospitals: 2022 Update. Infect Control Hosp Epidemiol 44:1209–1231. https://doi.org/10.1017/ice.2023.137
doi: 10.1017/ice.2023.137 pubmed: 37620117
Chao C-T, Lee S-Y, Wang J et al (2021) Frailty increases the risk for developing urinary tract infection among 79,887 patients with diabetic mellitus and chronic kidney disease. BMC Geriatr 21:349. https://doi.org/10.1186/s12877-021-02299-3
doi: 10.1186/s12877-021-02299-3 pubmed: 34098883 pmcid: 8186134
Scherberich JE, Fünfstück R, Naber KG (2021) Urinary tract infections in patients with renal insufficiency and dialysis–epidemiology, pathogenesis, clinical symptoms, diagnosis and treatment. GMS Infect Dis 9
Ripa F, Pietropaolo A, Montanari E et al (2022) Association of kidney stones and recurrent utis: the chicken and egg situation. A systematic review of literature. Curr Urol Rep 23:165–174. https://doi.org/10.1007/s11934-022-01103-y
doi: 10.1007/s11934-022-01103-y pubmed: 35877059 pmcid: 9492590
Brain E, Geraghty RM, Cook P et al (2021) Risk of UTI in kidney stone formers: a matched-cohort study over a median follow-up of 19 years. World J Urol 39:3095–3101. https://doi.org/10.1007/s00345-020-03564-7
doi: 10.1007/s00345-020-03564-7 pubmed: 33403436 pmcid: 8405492
Yongzhi L, Shi Y, Jia L et al (2018) Risk factors for urinary tract infection in patients with urolithiasis—primary report of a single center cohort. BMC Urol 18:45. https://doi.org/10.1186/s12894-018-0359-y
doi: 10.1186/s12894-018-0359-y pubmed: 29783970 pmcid: 5963162

Auteurs

Rafik Aniba (R)

Team of Biotechnology and Sustainable Development of Natural Resources, Department of Biology, Polydisciplinary Faculty, Sultan Moulay Slimane University, Beni Mellal, Morocco. rafik.anibafpb@usms.ac.ma.
Molecular Bacteriology Laboratory, Pasteur Institute of Morocco, Casablanca, Morocco. rafik.anibafpb@usms.ac.ma.

Asmaa Dihmane (A)

Team of Biotechnology and Sustainable Development of Natural Resources, Department of Biology, Polydisciplinary Faculty, Sultan Moulay Slimane University, Beni Mellal, Morocco.

Habiba Raqraq (H)

Team of Biotechnology and Sustainable Development of Natural Resources, Department of Biology, Polydisciplinary Faculty, Sultan Moulay Slimane University, Beni Mellal, Morocco.

Amina Ressmi (A)

Team of Biotechnology and Sustainable Development of Natural Resources, Department of Biology, Polydisciplinary Faculty, Sultan Moulay Slimane University, Beni Mellal, Morocco.

Kaotar Nayme (K)

Molecular Bacteriology Laboratory, Pasteur Institute of Morocco, Casablanca, Morocco.

Mohammed Timinouni (M)

Laboratoire de Biotechnologie et bio-Informatique, Ecole des Hautes Etudes de Biotechnologie et de santé (EHEB), Casablanca, Morocco.

Abouddihaj Barguigua (A)

Team of Biotechnology and Sustainable Development of Natural Resources, Department of Biology, Polydisciplinary Faculty, Sultan Moulay Slimane University, Beni Mellal, Morocco.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH